The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Direct Fluorescence Monitoring of the Delivery and Cellular Uptake of a Cancer-Targeted RGD Peptide-Appended Naphthalimide Theragnostic Prodrug
Abstract
Presented here is a multicomponent synthetic strategy that allows for the direct, fluorescence-based monitoring of the targeted cellular uptake and release of a conjugated therapeutic agent. Specifically, we report here the design, synthesis, spectroscopic characterization, and preliminary in vitro biological evaluation of a RGD peptide-appended naphthalimide pro-CPT (compound 1). Compound 1 is a multifunctional molecule composed of a disulfide bond as a cleavable linker, a naphthalimide moiety as a fluorescent reporter, an RGD cyclic peptide as a cancer-targeting unit, and camptothecin (CPT) as a model active agent. Upon reaction with free thiols in aqueous media at pH 7.4, disulfide cleavage occurs. This leads to release of the free CPT active agent, as well as the production of a red-shifted fluorescence emission (λ(max) = 535 nm). Confocal microscopic experiments reveal that 1 is preferentially taken up by U87 cells over C6 cells. On the basis of competition experiments involving okadaic acid, an inhibitor of endocytosis, it is concluded that uptake takes place via RGD-dependent endocytosis mechanisms. In U87 cells, the active CPT payload is released within the endoplasmic reticulum, as inferred from fluorescence-based colocalization studies using a known endoplasmic reticulum-selective dye. The present drug delivery system (DDS) could represent a new approach to so-called theragnostic agent development, wherein both a therapeutic effect and drug uptake-related imaging information are produced and can be readily monitored at the subcellular level. In due course, the strategy embodied in conjugate 1 could allow for more precise monitoring of dosage levels, as well as an improved understanding of cellular uptake and release mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,658
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Glutathione in Cancer Biology and Therapy
Estrela, J. M., Ortega, A., & Obrador, E. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523878 · Cited by 1,041
Development of DNA aptamers using Cell-SELEX
Sefah, K., Shangguan, D., Xiong, X., O'Donoghue, M. B., & Tan, W. (2010) · Nature Protocols · doi:10.1038/nprot.2010.66 · Cited by 918
Krop, I. E., Beeram, M., Modi, S., Jones, S. F., Holden, S. N., Yu, W., Girish, S., Tibbitts, J., Yi, J.-H., Sliwkowski, M. X., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2071 · Cited by 595
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
Hertzberg, R. P., Caranfa, M. J., & Hecht, S. M. (1989) · Biochemistry · doi:10.1021/bi00437a018 · Cited by 551
Recent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 490
Temming, K., Schiffelers, R. M., Molema, G., & Kok, R. J. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.10.002 · Cited by 467
Lee, M. H., Han, J. H., Kwon, P.-S., Bhuniya, S., Kim, J. Y., Sessler, J. L., Kang, C., & Kim, J. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210065g · Cited by 408
Self-citationVitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours
Russell-Jones, G., McTavish, K., McEwan, J., Rice, J., & Nowotnik, D. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.07.009 · Cited by 392
Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics
Gerweck, L. E., Vijayappa, S., & Kozin, S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0024 · Cited by 362
Prodrugs for improving tumor targetability and efficiency
Mahato, R., Tai, W., & Cheng, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.002 · Cited by 353
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Hsiang, Y. H., Liu, L. F., Wall, M. E., Wani, M. C., Nicholas, A. W., Manikumar, G., Kirschenbaum, S., Silber, R., & Potmĕsil, M. (1989) · PubMed · Cited by 339
Jain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298
Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
Zhang, X., Xiong, Z., Wu, Y., Cai, W., Tseng, J. R., Gambhir, S. S., & Chen, X. S. (2006) · PubMed · Cited by 282
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Chen, X., Plasencia, C., Hou, Y., & Neamati, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049165z · Cited by 256
Drug targeting with nano-sized carrier systems
Yokoyama, M. (2005) · Journal of Artificial Organs · doi:10.1007/s10047-005-0285-0 · Cited by 232
Endogenous lectins as targets for drug delivery
Yamazaki, N., Kojima, S., Bovin, N. V., André, S., Gabius, S., & Gabius, H.-J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00071-5 · Cited by 200
Grogan, T. M., Fenoglio-Prieser, C., Zeheb, R., Bellamy, W., Frutiger, Y., Vela, E., Stemmerman, G., Macdonald, J., Richter, L., Gallegos, A., et al. (2000) · Human Pathology · doi:10.1053/hp.2000.6546 · Cited by 188
Cai, W., Wu, Y., Chen, K., Cao, Q., Tice, D. A., & Chen, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1480 · Cited by 187
Synthesis and activity of a folate peptide camptothecin prodrug
Henne, W. A., Doorneweerd, D. D., Hilgenbrink, A. R., Kularatne, S. A., & Low, P. S. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.076 · Cited by 157
Carriers in the Topical Treatment of Skin Disease
Körting, H. C., & Schäfer‐Korting, M. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_15 · Cited by 132
Landowski, C. P., Vig, B. S., Song, X., & Amidon, G. L. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0290 · Cited by 113
Zheng, Z.-B., Zhu, G., Tak, H., Joseph, E., Eiseman, J. L., & Creighton, D. J. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0499634 · Cited by 89
de Groot, F. M. H., Broxterman, H. J., Adams, H. P. H. M., van Vliet, A., TESSER, G. I., Elderkamp, Y. W., Schraa, A. J., Kok, R. J., Molema, G., Pinedo, H. M., et al. (2002) · PubMed · Cited by 86
Cao, Q., Li, Z., Chen, K., Wu, Z., He, L., Neamati, N., & Chen, X. S. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0744-y · Cited by 79
Hamann, P. R., Hinman, L. M., Beyer, C. F., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049795f · Cited by 74
Quiles, S., Raisch, K. P., Sanford, L. L., Bonner, J. A., & Safavy, A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900899g · Cited by 70
Hinchliffe, K. A., Irvine, R. F., & Divecha, N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01042.x · Cited by 64
Huang, B., Desai, A. M., Tang, S., Thomas, T. P., & Baker, J. R. (2010) · Organic Letters · doi:10.1021/ol1002626 · Cited by 63
Saksena, S., Shao, Y., Braunagel, S. C., Summers, M. D., & Johnson, A. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404934101 · Cited by 58
Boghaert, E. R., Sridharan, L., Khandke, K. M., Armellino, D. C., Ryan, M., Myers, K. A., Harrop, R., Kunz, A., Hamann, P., Marquette, K., et al. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.1.221 · Cited by 41
Applications for site-directed molecular imaging agents coupled with drug delivery potential
Wang, H., & Chen, X. S. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902889751 · Cited by 30
Yin, J., Li, Z., Yang, T., Wang, J., Zhang, X., & Zhang, Q. (2010) · Journal of drug targeting · doi:10.3109/10611861003663531 · Cited by 22
Holen, I., Gordon, P. B., STRØMHAUG, P. E., Berg, T., Fengsrud, M., Brech, A., Roos, N., Berg, T., & Seglen, P. O. (1995) · Biochemical Journal · doi:10.1042/bj3110317 · Cited by 19
Cited by
Small molecule-based ratiometric fluorescence probes for cations, anions, and biomolecules
Lee, M. H., Kim, J. S., & Sessler, J. L. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00280f · Cited by 1,642
Self-citationFluorescent chemical probes for accurate tumor diagnosis and targeting therapy
Gao, M., Yu, F., Lv, C., Choo, J., & Chen, L. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00908e · Cited by 827
Activatable Photosensitizers: Agents for Selective Photodynamic Therapy
Li, X., Kolemen, S., Yoon, J., & Akkaya, E. U. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604053 · Cited by 544
Theranostic Fluorescent Probes
Sharma, A., Verwilst, P., Li, M., Ma, D., Singh, N., Yoo, J., Kim, Y., Yang, Y., Zhu, J.-H., Huang, H., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00778 · Cited by 499
Self-citationChen, X., Xu, C., Wang, T., Zhou, C., Du, J., Wang, Z., Xu, H., Xie, T., Bi, G., Jiang, J., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601252 · Cited by 445
Metadata
- Authors
- Lee, M. H., Kim, J. Y., Han, J. H., Bhuniya, S., Sessler, J. L., Kang, C., & Kim, J. S.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-06-06
- Volume
- 134
- Issue
- 30
- Pages
- 12668-12674
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2086415594
- Cited by
- 309
- References
- 39
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
